Q32 Bio Inc. Deferred Tax Assets, Tax Credit Carryforwards, Research
Q32 Bio Inc. (FIXX) had Deferred Tax Assets, Tax Credit Carryforwards, Research of $27.60 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Credit Carryforwards
us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $27.60M.
- 2024-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $46.55M.
- 2023-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $13.55M; Deferred Tax Assets, Tax Credit Carryforwards, Research as first filed $79.09M.
- 2022-12-31: Deferred Tax Assets, Tax Credit Carryforwards, Research $66.76M.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards, Research | Deferred Tax Assets, Tax Credit Carryforwards, Research as first filed |
|---|---|---|
| 2025-12-31 | $27.60M 10-K · filed 2026-03-10 | |
| 2024-12-31 | $46.55M 10-K · filed 2026-03-10 | |
| 2023-12-31 | $13.55M 10-K · filed 2025-03-11 | $79.09M 10-K · filed 2024-03-13 |
| 2022-12-31 | $66.76M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $51.70M 10-K · filed 2023-03-09 | |
| 2020-12-31 | $39.89M 10-K · filed 2022-03-23 | |
| 2019-12-31 | $25.33M 10-K · filed 2021-03-11 | |
| 2018-12-31 | $12.51M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $1.78M 10-K · filed 2019-03-12 |